Cargando…

Diffusion patterns of new anti-diabetic drugs into hospitals in Taiwan: the case of Thiazolidinediones for diabetes

BACKGROUND: Diffusion of new drugs in the health care market affects patients' access to new treatment options and health care expenditures. We examined how a new drug class for diabetes mellitus, thiazolidinediones (TZDs), diffused in the health care market in Taiwan. METHODS: Assuming that mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Yu-Wen, Huang, Weng-Foung, Lee, Yue-Chune, Kuo, Ken N, Tsai, Chia-Rung, Tsai, Yi-Wen
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042909/ https://www.ncbi.nlm.nih.gov/pubmed/21281475 http://dx.doi.org/10.1186/1472-6963-11-21

Ejemplares similares

The impact of the rare disease and Orphan Drug Act in Taiwan
por: Hsiang, Ning-Chun, et al.
Publicado: (2021)

Changes of the prescription of hormone therapy in menopausal women: An observational study in Taiwan
por: Huang, Weng-Foung, et al.
Publicado: (2007)

Price regulation, new entry, and information shock on pharmaceutical market in Taiwan: a nationwide data-based study from 2001 to 2004
por: Hsiao, Fei-Yuan, et al.
Publicado: (2010)

Socioeconomic disparities in preventable hospitalization among adults with diabetes in Taiwan: a multilevel modelling approach
por: Chen, Pei-Ching, et al.
Publicado: (2015)

The impact of universal National Health Insurance on population health: the experience of Taiwan
por: Lee, Yue-Chune, et al.
Publicado: (2010)

Thiazolidinediones: the Forgotten Diabetes Medications
por: Lebovitz, Harold E.
Publicado: (2019)

Thiazolidinedione Derivatives: In Silico, In Vitro, In Vivo, Antioxidant and Anti-Diabetic Evaluation
por: Sameeh, Manal Y., et al.
Publicado: (2022)

Multilocus genetic risk score for diabetic retinopathy in the Han Chinese population of Taiwan
por: Liao, Wen-Ling, et al.
Publicado: (2018)

Type 2 Diabetes: Uses of thiazolidinediones and insulin
por: T. Bloomgarden, Zachary
Publicado: (2011)

Impact of the pay-for-performance program on lower extremity amputations in patients with diabetes in Taiwan
por: Sheen, Yi-Jing, et al.
Publicado: (2018)

Factors Related to Diabetes Mellitus in the Middle-Aged and Over in Taiwan
por: Liang, Chia-Chun, et al.
Publicado: (2020)

Beneficial Effects of Thiazolidinediones on Diabetic Nephropathy in OLETF Rats
por: Lee, Mi Young, et al.
Publicado: (2007)

Redefining the role of thiazolidinediones in the management of type 2 diabetes
por: Barnett, Anthony H
Publicado: (2009)

The effect of metformin and thiazolidinedione use on lung cancer in diabetics
por: Mazzone, Peter J, et al.
Publicado: (2012)

Efficacy and safety of thiazolidinediones in diabetes patients with renal impairment: a systematic review and meta-analysis
por: Wang, Wen, et al.
Publicado: (2017)

Treatment patterns in diabetic macular edema in Taiwan: a retrospective chart review
por: Sheu, Shwu-Jiuan, et al.
Publicado: (2018)

Healthy Life Expectancies by the Effects of Hypertension and Diabetes for the Middle Aged and Over in Taiwan
por: Liang, Chia-Chun, et al.
Publicado: (2020)

Risk of Fracture with Thiazolidinediones: Disease or Drugs?
por: Bazelier, Marloes T., et al.
Publicado: (2012)

Bone Loss in Diabetes: Use of Antidiabetic Thiazolidinediones and Secondary Osteoporosis
por: Lecka-Czernik, Beata
Publicado: (2010)

An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2022)

Thiazolidinediones lower the risk of pneumonia in patients with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Prospective Validation of American Diabetes Association Risk Tool for Predicting Pre-Diabetes and Diabetes in Taiwan–Taichung Community Health Study
por: Li, Chia-Ing, et al.
Publicado: (2011)

Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysis
por: Lin, Chu, et al.
Publicado: (2023)

Risk of skin cancer in patients with diabetes mellitus: A nationwide retrospective cohort study in Taiwan
por: Tseng, Hui-Wen, et al.
Publicado: (2016)

Cyclic Stretch Facilitates Myogenesis in C2C12 Myoblasts and Rescues Thiazolidinedione-Inhibited Myotube Formation
por: Chang, Ya-Ju, et al.
Publicado: (2016)

Cardiovascular Risk Factors Increase the Risks of Diabetic Peripheral Neuropathy in Patients With Type 2 Diabetes Mellitus: The Taiwan Diabetes Study
por: Yang, Chun-Pai, et al.
Publicado: (2015)

Peer Pressure, Psychological Distress and the Urge to Smoke
por: Tsai, Yi-Wen, et al.
Publicado: (2009)

Medical Risk Factors Associated with Cholangiocarcinoma in Taiwan: A Population-Based Case-Control Study
por: Chang, Jeffrey S., et al.
Publicado: (2013)

Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes
por: Stafford, John M, et al.
Publicado: (2007)

Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis
por: Zhang, Zhiwei, et al.
Publicado: (2017)

Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
por: Bae, Jaehyun, et al.
Publicado: (2021)

Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study
por: Chiu, Hsien-Tsai, et al.
Publicado: (2017)

Thiazolidinediones and the risk of asthma exacerbation among patients with diabetes: a cohort study
por: Rinne, Seppo T, et al.
Publicado: (2014)

Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis
por: Liu, Yang, et al.
Publicado: (2018)

Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary Disease
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Thiazolidinedione derivatives as novel GPR120 agonists for the treatment of type 2 diabetes
por: Wang, Xuekun, et al.
Publicado: (2022)

Thiazolidinediones: An In–Depth Study of Their Synthesis and Application to Medicinal Chemistry in the Treatment of Diabetes Mellitus
por: Long, Nathan, et al.
Publicado: (2021)

Thiazolidinedione use and risk of Parkinson’s disease in patients with type 2 diabetes mellitus
por: Zhao, Houyu, et al.
Publicado: (2022)

Use of thiazolidinediones and risk of hip fracture in old people in a case–control study in Taiwan
por: Lin, Hsien-Feng, et al.
Publicado: (2017)

Chemotherapy and Chemoprevention by Thiazolidinediones
por: Fröhlich, Eleonore, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r75jojtg7nmtacml186gbg8vvh